Carrie Bourdow - Trevena Senior Vice President Chief Commercial Officer
| TRVNDelisted Stock | USD 1.98 0.18 10.00% |
President
Ms. Carrie L. Bourdow is President, Chief Executive Officer, Director of the Company. Ms. Bourdow was appointed President, Chief Executive Officer, and member of our Board of Directors in October 2018. Ms. Bourdow joined our company as our Senior Vice President and Chief Commercial Officer in May 2015 and was appointed Executive Vice President and Chief Operating Officer in January 2018. From May 2013 to May 2015, she was Vice President of Marketing at Cubist Pharmaceuticals, Inc. Prior to joining Cubist in 2013, Ms. Bourdow served for more than 20 years at Merck Co., Inc., where she held positions of increasing responsibility across several therapeutic areas including antiinfectives, acute heart failure, and pain. Ms. Bourdow has served as a director of Nabriva Therapeutics PLC since June 2017 since 2018.
| Age | 61 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 610 354 8840 |
| Web | https://www.trevena.com |
Carrie Bourdow Latest Insider Activity
Tracking and analyzing the buying and selling activities of Carrie Bourdow against Trevena stock is an integral part of due diligence when investing in Trevena. Carrie Bourdow insider activity provides valuable insight into whether Trevena is net buyers or sellers over its current business cycle. Note, Trevena insiders must abide by specific rules, including filing SEC forms every time they buy or sell Trevena'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Carrie Bourdow over a month ago Disposition of 1055 shares by Carrie Bourdow of Trevena at 1.47 subject to Rule 16b-3 |
Trevena Management Efficiency
The company has return on total asset (ROA) of (0.7151) % which means that it has lost $0.7151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.1458) %, meaning that it created substantial loss on money invested by shareholders. Trevena's management efficiency ratios could be used to measure how well Trevena manages its routine affairs as well as how well it operates its assets and liabilities.Trevena currently holds 35.23 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Trevena has a current ratio of 5.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Trevena's use of debt, we should always consider it together with its cash and equity.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. Trevena (TRVN) is traded on NASDAQ Exchange in USA. It is located in 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087 and employs 23 people. Trevena is listed under Pharmaceutical Products category by Fama And French industry classification. Management Performance
| Return On Equity | -10.15 | ||||
| Return On Asset | -0.72 |
Trevena Leadership Team
Elected by the shareholders, the Trevena's board of directors comprises two types of representatives: Trevena inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trevena. The board's role is to monitor Trevena's management team and ensure that shareholders' interests are well served. Trevena's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trevena's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Demitrack, Senior Vice President and Chief Medical Officer | ||
| Michael Catalano, Vice Marketing | ||
| Howard MD, Consultant Founder | ||
| Robert Yoder, Senior Vice President and Chief Business Officer | ||
| Mark MD, Senior Officer | ||
| Carrie Bourdow, Senior Vice President Chief Commercial Officer | ||
| Patricia Drake, Senior Officer | ||
| Barry Shin, Senior CFO | ||
| Joel Solomon, General VP |
Trevena Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Trevena a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.15 | ||||
| Return On Asset | -0.72 | ||||
| Operating Margin | (20.01) % | ||||
| Current Valuation | 21.78 M | ||||
| Shares Outstanding | 852.93 K | ||||
| Shares Owned By Insiders | 0.79 % | ||||
| Shares Owned By Institutions | 8.77 % | ||||
| Number Of Shares Shorted | 59.36 K | ||||
| Price To Earning | (0.80) X | ||||
| Price To Book | 0.36 X |
Pair Trading with Trevena
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Trevena position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevena will appreciate offsetting losses from the drop in the long position's value.Moving together with Trevena Stock
Moving against Trevena Stock
| 0.74 | VCYT | Veracyte | PairCorr |
| 0.56 | VERA | Vera Therapeutics | PairCorr |
| 0.55 | DMAC | DiaMedica Therapeutics Trending | PairCorr |
| 0.51 | VAXX | Vaxxinity | PairCorr |
| 0.47 | DRTS | Alpha Tau Medical | PairCorr |
The ability to find closely correlated positions to Trevena could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Trevena when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Trevena - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Trevena to buy it.
The correlation of Trevena is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Trevena moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Trevena moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Trevena can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Trevena Stock
If you are still planning to invest in Trevena check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trevena's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |